Genetic screening for hereditary diffuse gastric cancer

References

• Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epiclemiol Rev 8, 1–27 (1986).
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Lucchini F, Negri E eta]. Trends of cancer mortality in Europe, 1955–1989:1, digestive sites. Eur. Cancer 28(1), 132–235 (1992).
   Google Scholar
• Miller BA, Kolonel LN, Bernstein L etal (eds). Racial/Ethnic Patterns of Cancer in the United States 1988–1992, National Cancer Institute. MHPub. No. 96–4104, Bethesda, MD, USA (1996).
   Google Scholar
• Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur.j Cancer33(7), 1075–1107 (1997).
   Google Scholar
• Zanghieri G, Di Gregorio C, Sacchetti C et al Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66 (9), 2047-2051 (1990).
   Google Scholar
• Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MET. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. j Natl Cancer Inst. 86(21), 1600–1608 (1994).
   PubMedGoogle Scholar
• Maser MJ. Linking Helicobacter pylori to gastric cancer. Nature Merl 6(4), 376–377 (2000).
   PubMedGoogle Scholar
• Ekström AM, Hansson LE, Signorello LB et al Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma — a population-based study in Sweden. BE J. Cancer 83(3), 391–396 (2000).
   Google Scholar
• Palli D, Galli M, Caporaso NE etal Family history and risk of stomach cancer in Italy. Cancer Epiclemiol Biomarker s Prey. 3(1), 15–18 (1994).
   Google Scholar
• Carneiro E Classification of gastric carcinomas. CUI7: Diag. Pathol 4,51-59 (1997). iiLauren P The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Mcrobiol Scam 64,31–49 (1965).
   Google Scholar
• Correa P Human gastric carcinogenesis: a multistep and multifactorial process — First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52(24), 6735–6740 (1992).
   Google Scholar
• Maehara Y, Watanabe A, Kakeji Y etal Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. BE j Cancer65(3), 417–420 (1992).
   Google Scholar
• Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl Merl 333(1), 32–41 (1995).
   PubMed Web of Science ®Google Scholar
• Caldas C, Carneiro F, Lynch HT etal Familial gastric cancer: overview and guidelines for management. J. Merl Genet. 36(12), 873–880 (1999). Defines the guidelines for management of hereditary diffuse gastric cancer (HDGC).
   Google Scholar
• Sokoloff B. Predisposition to cancer in the Bonaparte family. A117. I Surg. 40,673-678 (1938).
   Google Scholar
• Seruca R, Carneiro F, Castedo S eta]. Familial gastric polyposis revisited. Autosomal dominant inheritance confirmed. Cancer Genet. Cytogenet. 53(1), 97–100 (1991).
   Google Scholar
• Guilford P, Hopkins J, Harraway J et al E- cadherin germline mutations in familial gastric cancer. Nature 392(6674) 402–405 (1998). Describes for the first time CDH1 germline mutations in HDGC.
   Google Scholar
• Gayther SA, Gorringe KL, Ramus SJ etal Identification of germline E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 58(18), 4086–4089 (1998).
   Google Scholar
• Richards FM, McKee SA, Rajpar MH et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum. MoL Genet. 8(4), 607–610 (1999).
   Google Scholar
• Guilford PJ, Hopkins JB, Grady WM eta]. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum. Mutat. 14(3), 249–255 (1999).
   Google Scholar
• Lehtola J. Family study of gastric carcinoma with special reference to histological types. £and.j Gastroenterol 13\(Suppl. 50), 1–73 (1978).
   Google Scholar
• Shinmura K, Kohno T, Takahashi M eta]. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Caminogenesis 20 (6), 1127–1131 (1999).
   Google Scholar
• Bevan S, Houlston RS. Genetic predisposition to gastric cancer. QJM92(1), 5–10 (1999).
   PubMedGoogle Scholar
• El-Omar EM, Carrington M, Chow WH eta]. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776), 398–402 (2000).
   Google Scholar
• Machado JC, Pharoah P, Sousa S eta]. Interleukin-lb and interleukin-1 receptor antagonist gene polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology121 (4), 823–829 (2001).
   Google Scholar
• Yea SS, Yang YI, Jang WH etal Association between TNF-a promoter polymorphism and Helicobacter pylori cagA subtype infection. j Clin. Pathol 54(9), 703–706 (2001).
   Google Scholar
• Berx G, Cleton-Jansen AM, Nollet F et al E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMI30 14(24), 6107–6115 (1995).
   Google Scholar
• Shore EM, Nelson WJ. Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. j Biol. Chem. 266(29), 19672–19680 (1991).
   Google Scholar
• Berx G, Becker KF, Hofler H, van Roy Mutations of the human E-cadherin (CDH1) gene. Hum. Mutat. 12(4), 226–237 (1998).
   Google Scholar
• •Review of CDH1 somatic mutations.
   Google Scholar
• Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9(9), 317–321 (1993).
   Google Scholar
• Overduin M, Harvey TS, Bagby S eta]. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267 (5196), 386–389 (1995).
   PubMed Web of Science ®Google Scholar
• Shapiro L, Fannon AM, Kwong PD etal Structural basis of cell—cell adhesion by cadherins. Nature 374 (6520), 327–337 (1995).
   PubMedGoogle Scholar
• Nagar B, Overduin M, Ikura M, Rini JM. Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature 380 (6572), 360–364 (1996) .
   PubMed Web of Science ®Google Scholar
• Blaschuk OW Sullivan R, David S, Pouliot Y. Identification of a cadherin cell adhesion recognition sequence. Dev. Biol. 139(1), 227–229 (1990).
   PubMedGoogle Scholar
• Leckband D, Sivasankar S. Mechanism of homophilic cadherin adhesion. CI.117: Opin. Cell Biol. 12(5), 587–592 (2000).
   Google Scholar
• Reynolds AB, Daniel J, McCrea PD etal Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Bio1.14(12), 8333–8342 (1994).
   Google Scholar
• Willert K, Nusse R. P-catenin: a key mediator of Wnt signaling. G117: Opin. Genet. Dev. 8(1), 95–102 (1998).
   Google Scholar
• Polakis P Wnt signaling and cancer. Genes Dev. 14(15), 1837–1851 (2000).
   Google Scholar
• Lame L, Ohsugi M, Hirchenhain J, Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl Acad. Sci. USA 91(17), 8263–8267 (1994).
   Google Scholar
• Riethmacher D, Brinkmann V, Birchmeier C. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl Acad. Sci. USA 92 (3), 855–859 (1995).
   Google Scholar
• Becker IKF, Atkinson MJ, Reich U etal E- cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54(14), 3845–3852 (1994).
   Google Scholar
• Becker KF, Reich U, Schott C etal Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online Hum. Mutat. 13(2), 171 (1999).
   Google Scholar
• Muta H, Noguchi M, Kanai Y etal E- cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpnj Cancer Res. 87(8), 843–848 (1996).
   Google Scholar
• Machado JC, Soares P, Carneiro F eta]. E- cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab. Invest. 79(4) 459–465 (1999).
   Google Scholar
• Tamura G, Sakata K, Nishizuka S etal Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpnj Cancer Res. 87(11), 1153–1159 (1996).
   Google Scholar
• Oda T, Kanai Y, Oyama T etal E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl Acad. Sci. USA 91(5), 1858–1862 (1994).
   Google Scholar
• Graff JR, Herman JG, Lapidus RG etal E- cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55(22), 5195–5199 (1995).
   Google Scholar
• Hennig G, Behrens J, Truss M etal Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogenell(3), 475–484 (1995).
   Google Scholar
• Machado JC, Oliveira C, Carvalho R etal E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20(12), 1525–1528 (2001).
   Google Scholar
• Iida S, Akiyama Y, Ichikawa W etal Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds. Clin. Cancer Res. 5(6), 1445–1447 (1999).
   PubMedGoogle Scholar
• Yoon IKA, Ku JL, Yang HK etal Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. j Hum. Genet. 44(3), 177–180 (1999).
   Google Scholar
• Keller G, Vogelsang H, Becker I eta]. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am j Athol 155(2), 337–342 (1999).
   PubMed Web of Science ®Google Scholar
• •Describes a family with lobular breast and diffuse gastric cancer.
   Google Scholar
• Avizienyte E, Launonen V, Salovaara R, Kiviluoto T, Aaltonen L. E-cadherin is not frequently mutated in hereditary gastric cancer. 1 Merl Genet. 38(1), 49–52 (2001).
   Google Scholar
• Dussaulx-Garin L, Blayau M, Pagenault M etal A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. Eur Gastroenterol Hepatol 13(6), 711–715 (2001).
   PubMedGoogle Scholar
• Humar B, Toro T, Graziano F etal Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum. Mutat. 19(5), 518–525 (2002).
   Google Scholar
• Oliveira C, Bordin MC, Grehan N etal Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum. Mutat. 19(5),510–517 (2002).
   PubMedGoogle Scholar
• ••Describes CDH1 germline mutationsrestricted to HDGC families.
   Google Scholar
• Jonsson BA, Bergh A, Stattin p, Emmanuelsson M, Gronberg H. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int. Cancer 98 (6), 838–843 (2002) .
   Google Scholar
• Yabuta T, Shinmura K, Tani M etal E- cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int. j Cancer 101(5), 434–441 (2002).
   PubMedGoogle Scholar
• Grady WM, Willis J, Guilford PJ etal Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genet. 26(1), 16–17 (2000).
   Google Scholar
• ••Describes methylation of CDH1 promoteras the second genetic hit in HDGC.
   Google Scholar
• Li LC, Chui RM, Sasaki M etal A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60(4),873–876 (2000).
   Google Scholar
• Wu MS, Huang SP, Chang YT etal Association of the -160 C -> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94(5), 1443–1448 (2002).
   Google Scholar
• Pharoah PD, Oliveira C, Machado JC et al CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int. j Cancer 101(2)196-197 (2002).
   Google Scholar
• Vasen HF, Watson P, Mecidin JP, Lynch HT New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 (6), 1453–1456 (1999).
   PubMed Web of Science ®Google Scholar
• Varley JM, McGown G, Thorncroft M eta]. An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. j Merl Genet. 32(12), 942–945 (1995).
   Google Scholar
• Vasen HF, Sanders EA, Taal Bg et al The risk of brain tumors in hereditary non-polyposis colorectal cancer (HNPCC). Int.j Cancer65(4), 422–425 (1996).
   Google Scholar
• Aarnio M, Salovaara R, Aaltonen LA, Mecldin JP, Jarvinen HJ. Features of gastric cancer in hereditary nonpolyposis colorectal cancer syndrome. Int. j Cancer74(5), 551–555 (1997).
   Google Scholar
• Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. j Natl Cancer Inst. 90(14), 1039–1071 (1998).
   PubMedGoogle Scholar
• Leach FS, Nicolaides NC, Papadopoulos N et al Protein Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75 (6), 1215–1225 (1993).
   PubMed Web of Science ®Google Scholar
• Bronner CE, Baker SM, Morrison PT et al Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368(6468), 258–261 (1994).
   Google Scholar
• Papadopoulos N, Nicolaides NC, Wei YF etal Mutation of a mutL homolog in hereditary colon cancer. Science 263(5153), 1625–1629 (1994).
   PubMedGoogle Scholar
• Bapat B, Noorani H, Cohen Z et al Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut 44(5), 698–703 (1999).
   PubMedGoogle Scholar
• Wijnen J, van der Klift H, Vasen H etal MSH2 genomic deletions are a frequent cause of HNPCC. Nature Genet. 20(4), 326–328 (1998).
   Google Scholar
• Jiricny J. Mediating mismatch repair. Nature Genet. 24(1), 6–8 (2000).
   Google Scholar
• Papadopoulos N, Nicolaides NC, Liu B etal Mutations of GTBP in genetically unstable cells. Science 268(5219), 1915–1917 (1995).
   PubMedGoogle Scholar
• Miyaki M, Konishi M, Tanaka K etal Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genet. 17(3), 271–272 (1997).
   Google Scholar
• Varley JM, McGown G, Thomcroft M etal Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res. 57(15), 3245–3252 (1997).
   Google Scholar
• Bell DW, Varley JM, Szydlo TE etal Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286(5449), 2528–2531 (1999).
   Google Scholar
• Groden J, Thliveris A, Samowitz W et al Identification and characterization of the familial adenomatous polyposis coli gene. Ce1166(3), 589–600 (1991).
   Google Scholar
• Nishisho I, Nakamura Y, Miyoshi Y etal Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253(5020), 665–669 (1991).
   Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Ce//61(5), 759–767 (1990).
   Google Scholar
• Joslyn G, Carlson M, Thliveris A etal Identification of deletion mutations and three new genes at the familial polyposis locus. Ce1166(3), 601–613 (1991).
   Google Scholar
• Kinzler KW, Nilbert MC, Su LK etal Identification of FAP locus genes from chromosome 5q21. Science 253(5020), 661–665 (1991).
   Google Scholar
• Cross I, Delhanty J, Chapman P etal An intrachromosomal insertion causing 5q22 deletion and familial adenomatous polyposis coli in two generations. j Merl Genet. 29(3), 175–179 (1992).
   Google Scholar
• Mehenni H, Blouin JL, Radhakrishna U etal Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am.j Hum. Genet. 61(6), 1327–1334 (1997).
   Google Scholar
• Brownstein MET, Mehregan AH, Bilowski JB. Trichilemmomas in Cowden's disease. 161/1//A 238(1), 26 (1977) .
   Google Scholar
• Liaw D, Marsh DJ, Li J etal Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16(1), 64–67(1997).
   Google Scholar
• Marsh DJ, Dahia PL, Caron S etal Germline P7ENmutations in Cowden syndrome-like families. j Merl Genet. 35(11), 881–885 (1998).
   Google Scholar
• Snaddon J, Parkinson EK, Craft JA, Bartholomew C, Fulton R. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cellcarcinomas of the head and neck, despite loss of heterozygosity at this locus. Br. Cancer84(12), 1630–1634 (2001).
   Google Scholar
• Huntsman DG, Carneiro F, Lewis FR etal Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Eng. I Med. 344(25), 1904–1909 (2001). Demonstrates the severe limitations of the clinical screening for DGC in asymptomatic carriers of CDHlgermline mutations.
   Google Scholar
• Chun YS, Lindor NM, Smyrk TC etal. Germline E-cadherin gene mutations. Cancer92(1), 181–187 (2001).
   PubMedGoogle Scholar
• Berx G, Cleton-Jansen AM, Strumane K etal E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13(9), 1919–1925 (1996).
   PubMedGoogle Scholar
• Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroentemlogy121(6), 1348–1353. (2001). Paper providing estimates of the cumulative risk of gastric and breast cancer by age in CDH1 mutation carriers.
   Google Scholar
• Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. j Clin. Invest. 109(8), 987–991 (2002).
   Google Scholar
• Cano A, Perez-Moreno MA, Rodrigo I et al The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell. Biol. 2(2), 76–83 (2000).
   Google Scholar
• Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mal Cell 7 (6), 1267–1278 (2001).
   Google Scholar
• Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62(6),1613–1618 (2002).
   PubMed Web of Science ®Google Scholar
• Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, downregulates E-cadherin and promotes metastasis. Proc. Natl Acad. Sc]. USA 99(1), 365–370 (2002).
   Google Scholar
• Polakis P Wnt signaling and cancer. Genes Dev. 14(15),1837–1851 (2000).
   Google Scholar
• Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. fi-catenin is a target for the ubiquitin-proteasome pathway. EM130 I 16(13), 3797–3804 (1997).
   Google Scholar
• Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol. Chem. 272 (40), 24735–24738 (1997).
   Google Scholar
• Huber AH, Weis WI. The structure of the P-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by fi-catenin. Cell 105 (3), 391–402 (2001).
   PubMed Web of Science ®Google Scholar
• Fujita Y, Krause G, Scheffner M et al Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Natum Cell Biol. 4(3), 222–231 (2002).
   Google Scholar
• Sugimoto N, Imoto I, Fukuda Y et al IQGAP1, a negative regulator of cell—cell adhesion, is upregulated by gene amplification at 15q26 in gastric cancer cell lines H5C39 and 40A. J Hum. Genet. 46(1), 21–25 (2001).
   Google Scholar
• Takemoto H, Doki Y, Shiozaki H eta]. Localization of IQGAP1 is inversely correlated with intercellular adhesion mediated by e-cadherin in gastric cancers. hit.j Cancer 91 (6), 783–788 (2001).
   Google Scholar
• Li S, Wang Q, Chaldadar A, Bronson RT, Bernards A. Gastric hyperplasia in mice lacking the putative Cdc42 effector IQGAP1. Mol Cell Biol.697–701 (2000).
   Google Scholar
• Peng YF, Mandai K, Nakanishi H etal Restoration of E-cadherin-based cell-cell adhesion by overexpression of nectin in HSC-39 cells, a human signet ring cell gastric cancer cell line. Oncogene 21(26), 4108–4119 (2002).
   Google Scholar
• Ishii H, Baffa R, Numata SI eta]. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein and its expression is altered in multiple human tumors. Proc. Natl Acad. Sc]. USA 96(7), 3928–3933 (1999).
   Google Scholar
• Vecchione A, Ishii H, Shiao YH eta]. Fez]] lzts 1 alterations in gastric carcinoma. Clin. Cancer Res. 7(6), 1546–1552 (2001).
   Google Scholar
• Ishii H, Vecchione A, Murakumo Y etal FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc. Natl Acad. Sci. USA 98(18), 10374–10379 (2001).
   Google Scholar
• Sirard C, de la Pompa JL, Elia A eta]. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12(1), 107–119 (1998).
   Google Scholar
• Takaku K, Miyoshi H, Matsunaga A etal Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res. 59(24), 6113–6117 (1999).
   Google Scholar
• Holliston R, Bevan S, Williams A eta]. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome but only account for a minority of cases. Hum. Mal Genet. 7(12), 1907–1912 (1998).
   Google Scholar
• Howe JR, Roth S, Ringold JC eta]. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280(5366), 1086–1088 (1998).
   Google Scholar
• Li QL, Ito K, Sakakura C eta]. Causal relationship between the loss of RUNX3 expression and gastric cancer. Ce11109(1), 113–124 (2002).
   Google Scholar
• Kischkel PC, Lawrence DA, Tinel A etal Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. j Biol. Chem. 276(49), 46639–46646 (2001).
   Google Scholar
• Park WS, Lee JH, Shin MS. Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21(18), 2919–2925 (2002).
   Google Scholar